Colgate-Palmolive Company CL is in a good spot, thanks to its robust business strategies. Strong pricing and funding-the-growth and other productivity initiatives have been bolstering the company’s ...
Colgate-Palmolive Company CL has been gaining from strong pricing, and the benefits of funding growth and other productivity efforts. The company’s aggressive pricing actions, along with solid ...
Colgate-Palmolive is a Dividend King with a 62-year record of dividend growth and global dominance in oral care products. CL recently rebounded from a multi-year earnings decline, driven by its 2022 ...
Colgate-Palmolive (NYSE:CL) has appointed Dr. Christopher S. Boerner, CEO and Board Chair of Bristol Myers Squibb, to its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results